Abstract

 The use of electronic nicotine delivery systems and other vaping products is on the rise, and the health effects from these products remain uncertain.
 No evidence-based guidelines regarding the use of pharmacological vaping cessation interventions were identified.
 Some guidelines suggest that it may be reasonable to apply smoking cessation interventions and/or protocols for vaping cessation, but no guidance specific to the use of pharmacotherapy was identified.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
